Antiviral drugs (Record no. 127106)

MARC details
000 -LEADER
fixed length control field 01865nam a2200361 a 4500
001 - CONTROL NUMBER
control field 0000137957
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20171002061514.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m u
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100616s2011 njua sb 001 0 eng d
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
Canceled/invalid LC control number 2010025372
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9780470455630 (cloth)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9780470934685 (ePub)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9780470929353 (oBook)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9780470929346 (e-book)
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr10490613
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)746598445
040 ## - CATALOGING SOURCE
Original cataloging agency CaPaEBR
Transcribing agency CaPaEBR
050 14 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM411
Item number .A5753 2011eb
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615/.7924
Edition number 22
245 00 - TITLE STATEMENT
Title Antiviral drugs
Medium [electronic resource] :
Remainder of title from basic discovery through clinical trials /
Statement of responsibility, etc. edited by Wieslaw M. Kazmierski.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Hoboken, N.J. :
Name of publisher, distributor, etc. Wiley,
Date of publication, distribution, etc. c2011.
300 ## - PHYSICAL DESCRIPTION
Extent xiii, 438 p. :
Other physical details ill. (some col.)
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note pt. 1. Human immunodeficiency virus. section 1. HIV protease inhibitors ; section 2. HIV non-nucleoside reverse transcriptase inhibitors ; section 3. HIV nucleoside reverse transcriptase inhibitors ; section 4. HIV entry inhibitors ; section 5. HIV integrase inhibitors -- pt. 2. Hepatitis C virus. section 6. Protease inhibitors ; section 7. HCV polymerase nucleoside inhibitors ; section 8. Other HCV inhibitors -- pt. 3. Respiratory syncytial virus inhibitors -- pt. 4. Influenza, Hepatitis B, and Cytomegalovirus inhibitors.
533 ## - REPRODUCTION NOTE
Type of reproduction Electronic reproduction.
Place of reproduction Palo Alto, Calif. :
Agency responsible for reproduction ebrary,
Date of reproduction 2011.
Note about reproduction Available via World Wide Web.
-- Access may be limited to ebrary affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiviral agents.
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
Source of term local
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kazmierski, Wieslaw M.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element ebrary, Inc.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://site.ebrary.com/lib/daystar/Doc?id=10490613">http://site.ebrary.com/lib/daystar/Doc?id=10490613</a>
Public note An electronic book accessible through the World Wide Web; click to view
908 ## - PUT COMMAND PARAMETER (RLIN)
Put command parameter 170314
942 00 - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Electronic Book

No items available.